Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

Related Articles by Review for PubMed (Select 21079636)

1.

Paroxysmal extreme pain disorder: a molecular lesion of peripheral neurons.

Choi JS, Boralevi F, Brissaud O, Sánchez-Martín J, Te Morsche RH, Dib-Hajj SD, Drenth JP, Waxman SG.

Nat Rev Neurol. 2011 Jan;7(1):51-5. doi: 10.1038/nrneurol.2010.162. Epub 2010 Nov 16.

PMID:
21079636
2.

Familial pain syndromes from mutations of the NaV1.7 sodium channel.

Fischer TZ, Waxman SG.

Ann N Y Acad Sci. 2010 Jan;1184:196-207. doi: 10.1111/j.1749-6632.2009.05110.x. Review.

PMID:
20146699
3.

Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders.

Drenth JP, Waxman SG.

J Clin Invest. 2007 Dec;117(12):3603-9. Review.

4.

Genetics and molecular pathophysiology of Na(v)1.7-related pain syndromes.

Dib-Hajj SD, Yang Y, Waxman SG.

Adv Genet. 2008;63:85-110. doi: 10.1016/S0065-2660(08)01004-3. Review.

PMID:
19185186
5.

Familial trigeminal neuralgia: case reports and review of the literature.

Smyth P, Greenough G, Stommel E.

Headache. 2003 Sep;43(8):910-5. Review.

PMID:
12940815
6.

Sodium channel blockers for the treatment of neuropathic pain.

Bhattacharya A, Wickenden AD, Chaplan SR.

Neurotherapeutics. 2009 Oct;6(4):663-78. doi: 10.1016/j.nurt.2009.08.001. Review.

PMID:
19789071
7.

[The role of voltage-gated sodium channels in neuropathic pain].

Dong H, Hu SJ.

Sheng Li Ke Xue Jin Zhan. 2005 Jan;36(1):61-3. Review. Chinese. No abstract available.

PMID:
15881349
8.

Understanding neuropathic pain.

Zieglgänsberger W, Berthele A, Tölle TR.

CNS Spectr. 2005 Apr;10(4):298-308. Review.

PMID:
15788957
9.

Erythermalgia: molecular basis for an inherited pain syndrome.

Waxman SG, Dib-Hajj S.

Trends Mol Med. 2005 Dec;11(12):555-62. Epub 2005 Nov 8. Review.

PMID:
16278094
11.

Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain.

Waxman SG, Cummins TR, Dib-Hajj S, Fjell J, Black JA.

Muscle Nerve. 1999 Sep;22(9):1177-87. Review.

PMID:
10454712
12.

Neuropathic pain: mechanisms and treatments.

Ro LS, Chang KH.

Chang Gung Med J. 2005 Sep;28(9):597-605. Review.

13.

Ionic channels and neuropathic pain: physiopathology and applications.

Aurilio C, Pota V, Pace MC, Passavanti MB, Barbarisi M.

J Cell Physiol. 2008 Apr;215(1):8-14. doi: 10.1002/jcp.21280. Review.

PMID:
18205177
14.

Voltage-gated sodium channels: therapeutic targets for pain.

Dib-Hajj SD, Black JA, Waxman SG.

Pain Med. 2009 Oct;10(7):1260-9. doi: 10.1111/j.1526-4637.2009.00719.x. Review.

PMID:
19818036
15.

Blocking sodium channels to treat neuropathic pain.

Priest BT, Kaczorowski GJ.

Expert Opin Ther Targets. 2007 Mar;11(3):291-306. Review.

PMID:
17298289
16.

Anticonvulsants in neuropathic pain: rationale and clinical evidence.

Jensen TS.

Eur J Pain. 2002;6 Suppl A:61-8. Review.

PMID:
11888243
17.

Acquired channelopathies in nerve injury and MS.

Waxman SG.

Neurology. 2001 Jun 26;56(12):1621-7. Review.

PMID:
11428390
18.

Voltage-gated Na+ channels in neuropathic pain.

Hargus NJ, Patel MK.

Expert Opin Investig Drugs. 2007 May;16(5):635-46. Review.

PMID:
17461737
19.

[From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].

Drenth JP, te Morsche RH, Michiels JJ.

Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):194-6. Review. Dutch.

PMID:
16471234
20.

Voltage-gated sodium channel blockers for the treatment of neuropathic pain.

Cummins TR, Rush AM.

Expert Rev Neurother. 2007 Nov;7(11):1597-612. Review.

PMID:
17997706
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk